Cardiovascular Risk Assessment Panel

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

ADMA

SDMA

Apolipoprotein B

Chol/HDLC Ratio

Cholesterol, Total

Cholesterol is a waxy, fat-like substance that occurs naturally in all parts of the body. Your body needs some cholesterol to work properly. But if you have too much in your blood, it can combine with other substances in the blood and stick to the walls of your arteries. This is called plaque. Plaque can narrow your arteries or even block them. High levels of cholesterol in the blood can increase your risk of heart disease. Your cholesterol levels tend to rise as you get older. There are usually no signs or symptoms that you have high blood cholesterol, but it can be detected with a blood test. You are likely to have high cholesterol if members of your family have it, if you are overweight or if you eat a lot of fatty foods. You can lower your cholesterol by exercising more and eating more fruits and vegetables. You also may need to take medicine to lower your cholesterol.

HDL Cholesterol

HDL Large

Hs Crp

A high-sensitivity CRP (hs-CRP) test may be used by itself, in combination with other cardiac risk markers, or in combination with a lipoprotein-associated phospholipase A2 (Lp-PLA2) test that evaluates vascular inflammation. The hs-CRP test accurately detects low concentrations of C-reactive protein to help predict a healthy person's risk of cardiovascular disease (CVD). High-sensitivity CRP is promoted by some as a test for determining a person's risk level for CVD, heart attacks, and strokes. The current thinking is that hs-CRP can play a role in the evaluation process before a person develops one of these health problems.

LDL Medium

LDL Particle Number

LDL Pattern

LDL Peak Size

LDL Small

LDL-Cholesterol

Lipoprotein (A)

Lipoprotein-a, or Lp(a) are molecules made of proteins and fat. They carry cholesterol and similar substances through the blood. A high level of Lp(a) is considered a risk factor for heart disease. High levels of lipoproteins can increase the risk of heart disease. The test is done to check your risk of atherosclerosis, stroke, and heart attack.

LP PLA2 ACTIVITY

Non HDL Cholesterol

Triglycerides

Triglycerides are a form of fat and a major source of energy for the body. This test measures the amount of triglycerides in the blood. Most triglycerides are found in fat (adipose) tissue, but some triglycerides circulate in the blood to provide fuel for muscles to work. After a person eats, an increased level of triglycerides is found in the blood as the body converts the energy not needed right away into fat. Triglycerides move via the blood from the gut to adipose tissue for storage. In between meals, triglycerides are released from fat tissue to be used as an energy source for the body. Most triglycerides are carried in the blood by lipoproteins called very low density lipoproteins (VLDL). High levels of triglycerides in the blood are associated with an increased risk of developing cardiovascular disease (CVD), although the reason for this is not well understood. Certain factors can contribute to high triglyceride levels and to risk of CVD, including lack of exercise, being overweight, smoking cigarettes, consuming excess alcohol, and medical conditions such as diabetes and kidney disease.

Also known as: Fibrinogen Antigen Nephelometry

Fibrinogen Antigen,

Low levels of fibrinogen are associated with bleeding most commonly secondary to liver disease or Disseminated Intravascular Coagulation (DIC). Fibrinogen is an acute phase reactant and thus elevated levels may be associated with inflammation. Increased concentrations are also associated with increased risk of atherosclerosis.

ARACHIDONIC ACID

ARACHIDONIC ACID/EPA

DHA

DPA

EPA

EPA+DPA+DHA

LINOLEIC ACID

OMEGA-3 TOTAL

OMEGA-6 TOTAL

OMEGA-6/OMEGA-3 RATIO

OxLDL

TMAO (TRIMETHYLAMINE

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Cardiovascular Risk Assessment Panel panel contains 6 tests with 31 biomarkers.

The Cardiovascular Risk Assessment Panel is a comprehensive diagnostic tool designed to evaluate various biochemical markers associated with heart health and the risk of cardiovascular disease. This panel includes the following tests:

  1. ADMA/SDMA: These biomarkers help assess endothelial dysfunction, which can lead to atherosclerosis and cardiovascular disease. Elevated levels of ADMA and SDMA are associated with an increased risk of heart attack and stroke.

  2. CARDIO IQ(R) Advanced Lipid Panel and Inflammation Panel: This test provides a detailed profile of your lipid levels, including LDL, HDL, and triglycerides, along with inflammatory markers such as hs-CRP. This comprehensive analysis helps in identifying not just the risk of heart disease but also potential inflammation that could complicate existing cardiovascular conditions.

  3. Fibrinogen Antigen, Nephelometry: Fibrinogen is a blood clotting factor, and high levels can indicate an increased risk of clotting, which is a significant risk factor for stroke and heart attack. This test measures the actual amount of fibrinogen in the blood, providing insight into your blood's clotting potential.

  4. OMEGACHECK(TM): This test measures the levels of omega-3 fatty acids in the blood, which are crucial for heart health. Higher levels of omega-3 fatty acids are associated with a reduced risk of sudden cardiac events and can help manage triglyceride levels.

  5. OxLDL: Oxidized LDL is a form of LDL cholesterol that has reacted with free radicals. This type of cholesterol is particularly harmful and more likely to contribute to the formation of plaques in arteries. Testing for OxLDL can provide specific insight into the risk of developing atherosclerosis.

  6. TMAO (Trimethylamine N-oxide): TMAO is a metabolite produced by gut bacteria during digestion and linked to an increased risk of heart disease. High levels of TMAO can predict future cardiovascular events, including heart attacks and strokes.

Each test in the Cardiovascular Risk Assessment Panel provides valuable information that, when combined, offers a detailed picture of a person's cardiovascular health. This panel is particularly beneficial for individuals with a family history of heart disease, those with existing heart conditions, or anyone interested in a comprehensive evaluation of their heart health risks.

The integration of these diverse markers allows for a multifaceted approach to understanding an individual's heart health:

  • Comprehensive Assessment: By assessing lipid levels, inflammation, blood clotting capabilities, fatty acid composition, oxidative stress, and metabolic by-products, the panel provides a broad spectrum of data. This enables healthcare providers to tailor interventions more effectively based on a person's specific risk factors.

  • Early Detection: The panel is designed to detect subtle changes in various biomarkers that might not be visible through standard testing. Early detection of any imbalance can lead to earlier interventions, which may prevent serious cardiovascular diseases.

  • Personalized Health Management: With detailed insights from the panel, individuals can work closely with their healthcare providers to develop personalized health plans that may include lifestyle adjustments, dietary changes, and medications aimed at mitigating specific risk factors identified through the tests.

  • Monitoring and Follow-Up: For those already managing cardiovascular conditions or undergoing treatment, this panel is an excellent tool for monitoring the effectiveness of interventions and adjusting treatment plans as needed based on dynamic biomarker levels.

Ultimately, the Cardiovascular Risk Assessment Panel is a powerful ally in both preventing and managing cardiovascular disease, offering targeted insights that foster proactive health management and improved outcomes.

Customer Reviews